Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 20 of 31 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Clear Filters
An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients
- Condition(s):
- Chronic Obstructive Pulmonary Disease
- Status:
- Terminated
- Requirements:
- 20 Years to 75 Years
- Interventions:
- Drug: TV48108 | Drug: Placebo
Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients
- Condition(s):
- Stable Renal Transplant Recipients
- Status:
- Terminated
- Requirements:
- 18 Years and older
- Interventions:
- Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)
Comparing the Efficacy and Safety of Fremanezumab for Chronic Cluster Headache
- Condition(s):
- Chronic Cluster Headache
- Status:
- Terminated
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Disease Progression Study for the Treatment of RRMS
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Betaseron | Drug: Rebif
Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
- Condition(s):
- Growth Hormone-Deficiency
- Status:
- Terminated
- Requirements:
- 3 Years to 11 Years
- Interventions:
- Drug: TV-1106 | Drug: somatropin
Effect of a 5-Day Regimen on Peripheral Stem Cell Mobilization
- Condition(s):
- Healthy Participants
- Status:
- Terminated
- Requirements:
- 18 Years to 60 Years
- Interventions:
- Drug: Tbo-filgrastim
Efficacy and Safety of Fremanezumab for Episodic Cluster Headache
- Condition(s):
- Episodic Cluster Headache
- Status:
- Terminated
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Efficacy of QVAR vs. Flovent Diskus in Participants with Poorly Controlled Asthma
- Condition(s):
- Asthma
- Status:
- Terminated
- Requirements:
- 12 Years to 70 Years
- Interventions:
- Drug: Qvar | Drug: Flovent Diskus
Efficacy, Safety and Tolerability Study of Glatiramer Acetate in Subjects With Multiple Sclerosis
- Condition(s):
- Relapsing-Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Placebo
Evaluate the Safety and Efficacy of Reslizumab for Patients With Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Terminated
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab
Evaluation of Safety and Tolerability of Long-term TEV-50717 for Treatment of Tourette Syndrome
- Condition(s):
- Tourette Syndrome
- Status:
- Terminated
- Requirements:
- 6 Years to 17 Years
- Interventions:
- Drug: TEV-50717 | Drug: Placebo
Exploring the Long Term Safety, Tolerability and Clinical Effect of Laquinimod
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: Laquinimod | Drug: Placebo
Extension Study of Talampanel for Amyotrophic Lateral Sclerosis
- Condition(s):
- Amyotrophic Lateral Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 80 Years
- Interventions:
- Drug: Talampanel
Healthy and COPD Participants to Evaluate the Efficacy and Safety of Inhaled TV46017
- Condition(s):
- Chronic Obstructive Pulmonary Disease (COPD)
- Status:
- Terminated
- Requirements:
- 20 Years to 75 Years
- Interventions:
- Drug: TV46017 | Drug: Placebo
Long-Term Safety and Efficacy of Fremanezumab for the Prevention of Cluster Headache
- Condition(s):
- Cluster Headache
- Status:
- Terminated
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
- Condition(s):
- Glioblastoma Multiforme | Anaplastic Astrocytoma|Anaplastic Oligodendroglioma | Anaplastic Mixed Oligoastrocytoma
- Status:
- Terminated
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Talampanel
PK, Safety,and Efficacy of Omacetaxine in Patients With Chronic Myeloid Leukemia
- Condition(s):
- Chronic Myeloid Leukemia
- Status:
- Terminated
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Omacetaxine mepesuccinate
Safety, Tolerability and Effect of Laquinimod in Subjects With Relapsing Multiple Sclerosis
- Condition(s):
- Relapsing Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- Child, Adult, Older Adult
- Interventions:
- Drug: Laquinimod
Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Placebo | Drug: Prednisone
Study of TV-1106 in Growth Hormone-Deficient Adults
- Condition(s):
- Growth Hormone Deficiency
- Status:
- Terminated
- Requirements:
- 18 Years and older
- Interventions:
- Drug: TV-1106 | Drug: Placebo
